HPx1 expression is controlled by dietary heme and the E75 transcription factor. by Octavio A. C. Talyuli (4285141)

Data Sheet 1_Circulating prostaglandin E2 concentrations decrease at birth in premature lambs.docx by Timothy J. R. Panneflek (22702136)

Data Sheet 2_Circulating prostaglandin E2 concentrations decrease at birth in premature lambs.docx by Timothy J. R. Panneflek (22702136)

Decreased immunofluorescence during multiplex staining. by Sandrine Prost (38667)

“…<p>Serial sections were stained with 1 to 5 different markers (Marker 1, MHCII Qdot 705Vivid; Marker 2, HO1 Qdot 605Vivid; Marker 3, CD163 Qdot 565; Marker 4, CD206 Qdot 655Vivid; Marker 5, CD68 streptavidin Qdot 525). …”

SAA decreases the expression of adipocyte markers. by Aurélie Faty (169741)

G9a decreases Rhox5 expression. by Mayumi Sugimoto (151133)

G9a decreases Rhox5 expression. by Mayumi Sugimoto (151133)

GSK343 decreased tumor stemness. by Laura V. Bownes (10276762)

“…(C) COA6 cells were treated with GSK343 (0, 5 μM) for 72 hours. qPCR demonstrated a significant decrease in mRNA abundance of known stemness markers Oct4, Nanog, and Sox2 following GSK343 treatment compared to untreated cells. …”

Analysis of change in mature INPs, GMCs and neurons in the type II NB lineage on depletion of mitochondrial morphology proteins. by Dnyanesh Dubal (12085942)

Foxa1 decreases FA uptake. by Marta Moya (188959)

Surface active properties of lipid nanocapsules - Fig 5 by Celia R. A. Mouzouvi (4347937)

Decreased number of anastomoses in ICAS mice. by Jill M. Roberts (4760685)

A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E ε4 allele-0 by Ryan J Haasl (92283)

“…<p><b>Copyright information:</b></p><p>Taken from "A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E ε4 allele"</p><p>http://www.biomedcentral.com/1471-2350/9/37</p><p>BMC Medical Genetics 2008;9():37-37.…”

A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E ε4 allele-1 by Ryan J Haasl (92283)

“…<p><b>Copyright information:</b></p><p>Taken from "A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E ε4 allele"</p><p>http://www.biomedcentral.com/1471-2350/9/37</p><p>BMC Medical Genetics 2008;9():37-37.…”

Drp1^SD overexpression in <i>opa1</i> RNAi and <i>marf</i> RNAi expressing type II NB lineages suppresses the differentiation defect. by Dnyanesh Dubal (12085942)

Tethering transiently decreases the singing rate. by Homare Yamahachi (363988)

PD 98059 decreases the phosphorylation of ERK in HSVEC, but does not restore ATP-induced decrease in endothelial function in RA. by Padmini Komalavilas (402160)

CDA-2 decreases pulmonary inflammation. by Xuan Wang (55634)

Palmitate decreases adiponectin expression and secretion. by Shakun Karki (194655)

Jasplakinolide decreased late EPC proliferation. by Xiaoyun Zhang (115529)